To be fair, the biggest unknown that could be huge is the up-sell into the existing customer base for VNA and the other ollogies when they're released. I assume this will be zero cost upsells if customers are enjoying the PACS. The quantum is hardest to determine as Mercy VNA deal was about 3/4 the size of PACS deal. Does this mean the latent upsell value of existing customers is 2 to 4x current PACS and just a matter or time to happen? This on top of new customer wins.
To be fair, the biggest unknown that could be huge is the...
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$224.32 |
Change
9.700(4.52%) |
Mkt cap ! $17.90B | |||
| Open | High | Low | Value | Volume |
| $216.99 | $224.65 | $215.12 | $23.13M | 104.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 20 | $224.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $224.36 | 16 | 4 |
View Market Depth
| Last trade - 15.20pm 22/11/2024 (20 minute delay) ? |
| PME (ASX) Chart |
